Loading
PDBj
MenuPDBj@FacebookPDBj@TwitterPDBj@YouTubewwPDB FoundationwwPDB
RCSB PDBPDBeBMRBAdv. SearchSearch help

5NXS

Crystal Structure of Human Pro-myostatin Precursor at 4.2 A Resolution with Experimental Phases from SeMet labelling

Summary for 5NXS
Entry DOI10.2210/pdb5nxs/pdb
DescriptorGrowth/differentiation factor 8 (1 entity in total)
Functional Keywordsgrowth factor, signaling protein, tgfbeta family, cystine knot
Biological sourceHomo sapiens (Human)
Cellular locationSecreted : O14793
Total number of polymer chains2
Total formula weight76995.85
Authors
Cotton, T.R.,Fischer, G.,Hyvonen, M. (deposition date: 2017-05-10, release date: 2018-01-17, Last modification date: 2018-02-21)
Primary citationCotton, T.R.,Fischer, G.,Wang, X.,McCoy, J.C.,Czepnik, M.,Thompson, T.B.,Hyvonen, M.
Structure of the human myostatin precursor and determinants of growth factor latency.
EMBO J., 37:367-383, 2018
Cited by
PubMed Abstract: Myostatin, a key regulator of muscle mass in vertebrates, is biosynthesised as a latent precursor in muscle and is activated by sequential proteolysis of the pro-domain. To investigate the molecular mechanism by which pro-myostatin remains latent, we have determined the structure of unprocessed pro-myostatin and analysed the properties of the protein in its different forms. Crystal structures and SAXS analyses show that pro-myostatin adopts an open, V-shaped structure with a domain-swapped arrangement. The pro-mature complex, after cleavage of the furin site, has significantly reduced activity compared with the mature growth factor and persists as a stable complex that is resistant to the natural antagonist follistatin. The latency appears to be conferred by a number of distinct features that collectively stabilise the interaction of the pro-domains with the mature growth factor, enabling a regulated stepwise activation process, distinct from the prototypical pro-TGF-β1. These results provide a basis for understanding the effect of missense mutations in pro-myostatin and pave the way for the design of novel myostatin inhibitors.
PubMed: 29330193
DOI: 10.15252/embj.201797883
PDB entries with the same primary citation
Experimental method
X-RAY DIFFRACTION (4.19 Å)
Structure validation

226707

數據於2024-10-30公開中

PDB statisticsPDBj update infoContact PDBjnumon